الملخص
The association of education, tobacco smoking, alcohol consumption, and interleukin-2 (IL-2 +114 and -384) and -6 (IL-6 -174) DNA polymorphisms with head and neck squamous cell carcinoma (HNSCC) was investigated in a cohort study of 445 subjects. IL-2 and IL-6 genotypes were determined by real-time PCR. Cox regression was used to estimate hazard ratios (HR) and 95 percent confidence intervals (95 percentCI) of disease-specific survival according to anatomical sites of the head and neck. Mean age was 56 years and most patients were males (87.6 percent). Subjects with 5 or more years of schooling had better survival in larynx cancer. Smoking had no effect on HNSCC survival, but alcohol consumption had a statistically significant effect on larynx cancer. IL-2 gene +114 G/T (HR = 0.52; 95 percentCI = 0.15-1.81) and T/T (HR = 0.22; 95 percentCI = 0.02-3.19) genotypes were associated with better survival in hypopharynx cancer. IL-2 +114 G/T was a predictor of poor survival in oral cavity/oropharynx cancer and larynx cancer (HR = 1.32; 95 percentCI = 0.61-2.85). IL-2 -384 G/T was associated with better survival in oral cavity/oropharynx cancer (HR = 0.80; 95 percentCI = 0.45-1.42) and hypopharynx cancer (HR = 0.68; 95 percentCI = 0.21-2.20), but an inverse relationship was observed for larynx cancer. IL-6 -174 G/C was associated with better survival in hypopharynx cancer (HR = 0.68; 95 percentCI = 0.26-1.78) and larynx cancer (HR = 0.93; 95 percentCI = 0.42-2.07), and C/C reduced mortality in larynx cancer. In general, our results are similar to previous reports on the value of education, smoking, alcohol consumption, and IL-2 and IL-6 genetic polymorphisms for the prognosis of HNSCC, but the risks due to these variables are small and estimates imprecise.
الموضوعات
Aged , Female , Humans , Male , Middle Aged , Carcinoma, Squamous Cell/mortality , Head and Neck Neoplasms/mortality , /genetics , /genetics , Polymorphism, Genetic/genetics , Alcohol Drinking/adverse effects , Cohort Studies , Carcinoma, Squamous Cell/etiology , Disease-Free Survival , Educational Status , Genotype , Head and Neck Neoplasms/etiology , Prognosis , Risk Factors , Smoking/adverse effectsالملخص
MicroRNAs (miRNAs) are a class of small endogenous RNAs that play important regulatory roles by targeting mRNAs for cleavage or translational repression. miRNAs act in diverse biological processes including development, cell growth, apoptosis, and hematopoiesis, suggesting their association with cancer. We determined the miRNA expression profile of chronic and acute lymphocytic leukemias (CLL and ALL) using the TaqMan® MicroRNA Assays Human Panel (Applied Biosystems). Pooled leukemia samples were compared to pooled CD19+ samples from healthy individuals (calibrator) by the 2-DD Ct method. Total RNA input was normalized based on the Ct values obtained for hsa-miR-30b. The five most highly expressed miRNAs were miR-128b, miR-204, miR-218, miR-331, and miR-181b-1 in ALL, and miR-331, miR-29a, miR-195, miR-34a, and miR-29c in CLL. To our knowledge, this is the first report associating miR-128b, miR-204 and miR-331 to hematological malignancies. The miR-17-92 cluster was also found to be up-regulated in ALL, as previously reported for some types of lymphomas. The differences observed in gene expression levels were validated for miR-331 and miR-128b in ALL and CD19+ samples. These miRNAs were up-regulated in ALL, in agreement with our initial results. A brief target analysis was performed for miR-331. One of its putative targets, SOCS1, promotes STAT activation, which is a known mediator of cell proliferation and survival, suggesting the possibility of an association between miR-331 and these processes. This initial screening provided information on miRNA differentially expressed in normal and malignant B-cells that could suggest the potential roles of these miRNAs in hematopoiesis and leukemogenesis.
الموضوعات
Humans , Leukemia, Lymphocytic, Chronic, B-Cell/genetics , MicroRNAs/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Case-Control Studiesالملخص
Genomics is expanding the horizons of epidemiology, providing a new dimension for classical epidemiological studies and inspiring the development of large-scale multicenter studies with the statistical power necessary for the assessment of gene-gene and gene-environment interactions in cancer etiology and prognosis. This paper describes the methodology of the Clinical Genome of Cancer Project in São Paulo, Brazil (CGCP), which includes patients with nine types of tumors and controls. Three major epidemiological designs were used to reach specific objectives: cross-sectional studies to examine gene expression, case-control studies to evaluate etiological factors, and follow-up studies to analyze genetic profiles in prognosis. The clinical groups included patients' data in the electronic database through the Internet. Two approaches were used for data quality control: continuous data evaluation and data entry consistency. A total of 1749 cases and 1509 controls were entered into the CGCP database from the first trimester of 2002 to the end of 2004. Continuous evaluation showed that, for all tumors taken together, only 0.5 percent of the general form fields still included potential inconsistencies by the end of 2004. Regarding data entry consistency, the highest percentage of errors (11.8 percent) was observed for the follow-up form, followed by 6.7 percent for the clinical form, 4.0 percent for the general form, and only 1.1 percent for the pathology form. Good data quality is required for their transformation into useful information for clinical application and for preventive measures. The use of the Internet for communication among researchers and for data entry is perhaps the most innovative feature of the CGCP. The monitoring of patients' data guaranteed their quality.
الموضوعات
Adult , Child , Humans , Databases, Factual , Epidemiologic Studies , Human Genome Project , Internet , Neoplasms/genetics , Brazilالملخص
Serial analysis of gene expression (SAGE) technology produces large sets of interesting genes that are difficult to analyze directly. Bioinformatics tools are needed to interpret the functional information in these gene sets. We present an interactive web-based tool, called Gene Class, which allows functional annotation of SAGE data using the Gene Ontology (GO) database. This tool performs searches in the GO database for each SAGE tag, making associations in the selected GO category for a level selected in the hierarchy. This system provides user-friendly data navigation and visualization for mapping SAGE data onto the gene ontology structure. This tool also provides graphical visualization of the percentage of SAGE tags in each GO category, along with confidence intervals and hypothesis testing.
الموضوعات
Humans , Animals , Databases, Genetic , Expressed Sequence Tags , Gene Expression Profiling/methods , Software , Terminology , Internet , Models, Statisticalالملخص
Ala100Thr has been suggested to be a Caucasian genetic marker on the FY*B allele. As the Brazilian population has arisen from miscegenation among Portuguese, Africans, and Indians, this mutation could possibly be found in Euro- and Afro-Brazilians, or in Brazilian Indians. Fifty-three related individuals and a random sample of 100 subjects from the Brazilian population were investigated using the polymerase chain reaction and four restriction fragment length polymorphisms. Confirming the working hypothesis, among the related individuals three Afro-Brazilians (two of them a mother and daughter) and a woman of Amerindian descent had the Ala100Thr mutation on the FY*B allele. Five non-related Euro-Brazilians also carried the mutation. All nine individuals presented the Fy(a-b+) phenotype. We conclude that the Ala100Thr mutation can occur in populations other than Caucasians and that this mutation does not affect Duffy expression on red blood cells. Gene frequencies for this allele in the non-related individuals were in agreement with those of other populations. The Duffy frequencies of two Amerindian tribes were also investigated.
الموضوعات
Humans , Male , Female , Genetic Variation , Receptors, Cell Surface , Mutation/genetics , Duffy Blood-Group System/genetics , Brazil , Phenotype , Genotype , American Indian or Alaska Native/genetics , Black People/genetics , White People/genetics , Genetic Markers , Polymorphism, Restriction Fragment Length , Polymerase Chain Reactionالملخص
The spinal muscular atrophies (SMA) or hereditary motor neuronopathies result from the continuous degeneration and death of spinal cord lower motor neurons, leading to progressive muscular weakness and atrophy. We describe a large Brazilian family exhibiting an extremely rare, late-onset, dominant, proximal, and progressive SMA accompanied by very unusual manifestations, such as an abnormal sweating pattern, and gastrointestinal and sexual dysfunctions, suggesting concomitant involvement of the autonomic nervous system. We propose a new disease category for this disorder, `hereditary motor and autonomic neuronopathy', and attribute the term, `survival of motor and autonomic neurons 1' (SMAN1) to the respective locus that was mapped to a 14.5 cM region on chromosome 20q13.2-13.3 by genetic linkage analysis and haplotype studies using microsatellite polymorphic markers. This locus lies between markers D20S120 and D20S173 showing a maximum LOD score of 4.6 at D20S171, defining a region with 33 known genes, including several potential candidates. Identifying the SMAN1 gene should not only improve our understanding of the molecular mechanisms underlying lower motor neuron diseases but also help to clarify the relationship between motor and autonomic neurons.
الموضوعات
Humans , Male , Female , Chromosome Mapping/methods , /genetics , Hereditary Sensory and Motor Neuropathy/genetics , Genetic Markers , Genotype , Pedigree , Polymerase Chain Reactionالملخص
Levels of mtDNA(4977) deletions (DeltamtDNA(4977)) have been found to be lower in tumors than in adjacent non-tumoral tissues. In 87 cancer patients, DeltamtDNA(4977) was detected by multiplex polymerase chain reaction (PCR) amplification in 43 (49%) of the tumors and in 74 (85%) of the samples of non-tumoral tissues that were adjacent to the tumors. DeltamtDNA(4977) deletions were detected in 24% of the breast tumors, 52% of the colorectal tumors, 79% of the gastric tumors, and 40% of the head and neck tumors as compared with 77, 83, 100, and 90% of the adjacent respective non-tumoral tissues at the same DNA template dilution. Based on limiting dilution PCR of 16 tumors and their adjacent non-tumoral tissues, it was found that the amount of DeltamtDNA(4977) was 10- to 100-fold lower in the tumor than in the respective control non-tumoral tissues. Real-time PCR experiments were performed to quantify the number of DeltamtDNA(4977) deletions per cell, by determining the mitochondrial-to-nuclear DNA ratio. In all of the cases of breast, colorectal, gastric, and head and neck cancer the proportion of DeltamtDNA(4977) in tumors was lower than that of the respective non-tumoral tissue. Traces of DeltamtDNA(4977) in tumors were apparently due to contamination of tumor tissue with surrounding non-tumoral tissue, as evidenced by tumor microdissection and in situ PCR techniques, suggesting that tumors are essentially free of this mutation. Although the metabolic effect of DeltamtDNA(4977) may be minimal in normal (non-tumor) tissue, in tissue under stress, such as in tumors, even low levels of DeltamtDNA(4977) deletions may be intolerable.
الموضوعات
Female , Humans , Sequence Deletion/genetics , Mutation/genetics , Colorectal Neoplasms/genetics , Stomach Neoplasms/genetics , Breast Neoplasms/genetics , Head and Neck Neoplasms/genetics , Case-Control Studies , DNA, Mitochondrial/genetics , Polymerase Chain Reaction , Tumor Cells, Culturedالملخص
Studies that consider polymorphisms within the apolipoprotein B (apo B) gene as risk factors for coronary artery disease (CAD) have reported conflicting results. The aim of the present study was to search for associations between two DNA RFLPs (XbaI and EcoRI) of the apo B gene and CAD diagnosed by angiography. In the present study we compared 116 Brazilian patients (92 men) with CAD (CAD+) to 78 control patients (26 men) without ischemia or arterial damage (CAD-). The allele frequencies at the XbaI (X) and EcoRI (E) sites did not differ between groups. The genotype distributions of CAD+ and CAD- patients were different (chi²(1) = 6.27, P = 0.012) when assigned to two classes (X-X-/E+E+ and the remaining XbaI/EcoRI genotypes). Multivariate logistic regression analysis showed that individuals with the X-X-/E+E+ genotype presented a 6.1 higher chance of developing CAD than individuals with the other XbaI/EcoRI genotypes, independently of the other risk factors considered (sex, tobacco consumption, total cholesterol, hypertension, and triglycerides). We conclude that the X-X-/E+E genotype may be in linkage disequilibrium with an unknown variation in the apo B gene or with a variation in another gene that affects the risk of CAD
الموضوعات
Humans , Male , Female , Adult , Middle Aged , Apolipoproteins B , Coronary Disease , Deoxyribonuclease EcoRI , Deoxyribonucleases, Type II Site-Specific , Polymorphism, Genetic , Alleles , Case-Control Studies , Cross-Sectional Studies , Genetic Markers , Genotype , Multivariate Analysis , Polymorphism, Restriction Fragment Length , Prospective Studies , Risk Factorsالملخص
The purpose of the present study was to identify noninvasive methods to evaluate the severity of iron overload in transfusion-dependent ß-thalassemia and the efficiency of intensive intravenous therapy as an additional tool for the treatment of iron-overloaded patients. Iron overload was evaluated for 26 ß-thalassemia homozygous patients, and 14 of them were submitted to intensive chelation therapy with high doses of intravenous deferoxamine (DF). Patients were classified into six groups of increasing clinical severity and were divided into compliant and non-compliant patients depending on their adherence to chronic chelation treatment. Several methods were used as indicators of iron overload. Total gain of transfusion iron, plasma ferritin, and urinary iron excretion in response to 20 to 60 mg/day subcutaneous DF for 8 to 12 h daily are useful to identify iron overload; however, urinary iron excretion in response to 9 g intravenous DF over 24 h and the increase of urinary iron excretion induced by high doses of the chelator are more reliable to identify different degrees of iron overload because of their correlation with the clinical grades of secondary hemochromatosis and the significant differences observed between the groups of compliant and non-compliant patients. Finally, the use of 3-9 g intravenous DF for 6-12 days led to a urinary iron excretion corresponding to 4.1 to 22.4 percent of the annual transfusion iron gain. Therefore, continuous intravenous DF at high doses may be an additional treatment for these patients, as a complement to the regular subcutaneous infusion at home, but requires individual planning and close monitoring of adverse reactions
الموضوعات
Humans , Male , Female , Child, Preschool , Child , Adolescent , Adult , Middle Aged , beta-Thalassemia , Chelation Therapy , Deferoxamine , Iron , Iron Chelating Agents , Iron Overload , beta-Thalassemia , Blood Transfusion , Infusions, Intravenous , Multivariate Analysis , Patient Compliance , Severity of Illness Indexالملخص
Although iron can catalyze the production of free radicals involved in LDL lipid peroxidation, the contribution of iron overload to atherosclerosis remains controversial. The description of two mutations in the HFE gene (Cys282Tyr and His63Asp) related to hereditary hemochromatosis provides an opportunity to address the question of the association between iron overload and atherosclerosis. We investigated the prevalence of HFE mutations in 160 survivors of myocardial infarction with angiographically demonstrated severe coronary atherosclerotic disease, and in 160 age-, gender- and race-matched healthy control subjects. PCR amplification of genomic DNA followed by RsaI and BclI restriction enzyme digestion was used to determine the genotypes. The frequency of the mutant Cys282Tyr allele was identical among patients and controls (0.022; carrier frequency, 4.4 per cent), whereas the mutant His63Asp allele had a frequency of 0.143 (carrier frequency, 27.5 per cent) in controls and of 0.134 (carrier frequency, 24.5 per cent) in patients. Compound heterozygotes were found in 2 of 160 (1.2 per cent) controls and in 1 of 160 (0.6 per cent) patients. The finding of a similar prevalence of Cys282Tyr and His63Asp mutations in the HFE gene among controls and patients with coronary atherothrombotic disease, indirectly questions the possibility of an association between hereditary hemochromatosis and atherosclerosis.
الموضوعات
Humans , Male , Female , Adult , Middle Aged , Coronary Artery Disease/genetics , Genes, MHC Class I/genetics , Histocompatibility Antigens Class I/genetics , HLA Antigens/genetics , Mutation , Alleles , Gene Frequency , Hemochromatosis/geneticsالملخص
Familial hypercholesterolemia (FH) is a common autosomal disorder that affects about one in 500 individuals in most Western populations and is caused by a defect in the low-density-lipoprotein receptor (LDLr) gene. In this report we determined the molecular basis of FH in 59 patients from 31 unrelated Brazilian families. All patients were screened for the Lebanese mutation, gross abnormalities of the LDLr gene, and the point mutation in the codon 3500 of the apolipoprotein B-100 gene. None of the 59 patients presented the apoB-3500 mutation, suggesting that familial defective ApoB-100 (FDB) is not a major cause of inherited hypercholesterolemia in Brazil. A novel 4-kb deletion in the LDLr gene, spanning from intron 12 to intron 14, was characterized in one family. Both 5' and 3' breakpoint regions were located within Alu repetitive sequences, which are probably involved in the crossing over that generated this rearrangement. The Lebanese mutation was detected in 9 of the 31 families, always associated with Arab ancestry. Two different LDLr gene haplotypes were demonstrated in association with the Lebanese mutation. Our results suggest the importance of the Lebanese mutation as a cause of FH in Brazil and by analogy the same feature may be expected in other countries with a large Arab population, such as North American and Western European countries.
الموضوعات
Humans , Child, Preschool , Child , Adolescent , Adult , Middle Aged , Male , Female , Hyperlipoproteinemia Type II/diagnosis , Hyperlipoproteinemia Type II/genetics , Mutation/genetics , Alleles , Blotting, Southern , Brazil , DNA/analysis , Haplotypes , Lebanon/ethnology , Polymerase Chain Reaction , Receptors, LDL/geneticsالملخص
The molecular abnormality of a patient with thalassemia intermedia was identified by DNA amplification (PCR) combined with the of synthetic oligonucleotide probes. The patient is a homozygote for the T===>C substitution at position 6 of the first intervening sequence (IVS1-6) of the ß globin gene. On the basis of this finding, the family, which had been previously reported by us to be a carrier of an unusually mild ß-thalassemia gene, was actually the first example reported of the clinical and biochemical features of ß-thalassemia-Portuguese type
الموضوعات
Adult , Humans , beta-Thalassemia/genetics , Homozygote , Mutation , Polymerase Chain Reaction , Base Sequence , Oligonucleotide Probesالملخص
A frequência de alfa-talassemia determinada entre 41 pacientes com anemia falciforme, empregando análise de DNA com enzimas de restriçäo, demonstrou 9 (22%) heterozigotos alfa+ - talassêmicos (genótipo alfa-/alfa alfa), o que indica uma frequência gênica de 0,126. A comparaçäo dos dois grupos de pacientes com anemia falciforme, com três ou com quatro genes de globina alfa, mostrou VCM menor no primeiro grupo, ao passo que näo foram detectadas diferencas nos valores de HbF, HbA2 e hemoglobina total. Estes dados indicam uma elevada prevalência de alfa-talassemia na populaçäo negróide brasileira
الموضوعات
Humans , Anemia, Sickle Cell/blood , DNA Restriction Enzymes/analysis , Gene Frequency , Thalassemia/epidemiology , Black People , Brazilالملخص
The usual methods for the functional evaluation of the spleen in man are based on the measurement of a) spleen volume, b) spleen uptake of particles form the circulating blood, and c) morphlogical abnormalities of ciruclating erythrocytes. Analysis of clearance curves of damaged autologous erythrocytes, measurement of spleen size or volume by scintillation scantillation scanning and counting of erythrocytes with pits by interference contrast microscopy at present are the most widely used techniques. The most frequent causes of acquired fucntional abnormalities of the spleen are the sickle cell diseases, inflammatory intestinal diseases, immune complex diseases, chronic myelogenous leukemia, irradiation, hemophilia, and the hyposplenism of newborn infants and of the elderly. Usually there is a parallelism between spleen volume and functional capacity; however; "functional" hyposplenism or asplenia, i. e., an enlarged or normal-sized spleen with decreased function, has been observed in sickle cell syndromes and occasionally in chronic myelogenous leukemia and hemophilia
الموضوعات
Infant , Child, Preschool , Child , Adolescent , Adult , Middle Aged , Cats , Humans , Spleen/physiology , Erythrocyte Count , Spleen , Spleen/pathology , Spleen/physiopathology , Splenectomy , Splenomegaly/etiologyالملخص
Os espectros de absorçäo obtidos por ressonância eletrônica paramagnética (REP) após oxidaçäo, armazenamento e aqueciemnto de Hb Zurich revelaram numerosos sinais na regiäo de alto campo (g=-) que säo indicativos da formaçäo de hemicromos. Espectros de absorçäo ópticos na regiäo visível obtidos da Hb Zurich oxidada ou de seu precipitado formado espontaneamente mostram aspectos característico da formaçäo de hemicromos. Os sinais de REP aumentam em g =-2) proporcionalmente ao decréscimo em g =-6,37. Além do mais, a relaçäo entre os valores de absorbância em 540 nm (heme) e 280 nm (proteína) näo se alteram durante o aquecimento da Hb Zurich a 50-C e säo similares no precipitado espontâneo desta hemoglobina en na HbA. Estes achados indicam que näo há perda do heme durante os estágios iniciais da desnaturaçäo da Hb Zurich
الموضوعات
Humans , Male , Electron Spin Resonance Spectroscopy , Hemeproteins/biosynthesis , Hemoglobins, Abnormal/metabolism , Hemoglobins, Abnormal/analysis , Hot Temperatureالملخص
1. Clinical, hematological, genetic and peripheral blood globin synthesis studies were carried out on 17 symptomatic Brazilian thalassemics and ther parents who live in the northeast of Säo Paulo State. The group inclued 8 beta--thalassemia homozygotes, 7 carriers of at least one beta+ gene, one delta beta-/beta--thalassemia double heterozygote and one beta- homozygote also carrying the alfa-chain variant Hb Hasharon (alfa2 47 His beta2). 2. The mean non-alfa/alfa ratio for globin biosynthesis of the patients lacking HbA (beta- homozygotes and delta beta-/beta- double heterozygotes) was 0.26 ñ 0.11 ( mean ñSD), which is not statistically different from the value of 0.32 ñ 0.06 obtained for the carriers of at least one beta+ gene. In contrast, the mean non-alfa/alfa ratio for the thalassemia major patients (0.22 ñ 0.07) was significantly lower than that obtained for the milder cases (0.34 ñ 0.06) although the beta/alfa ratios for the parents of the two groups were similar. 3. The heterogeneity within this group of Brasilian patients having two thalassemic genes, i.e. 60% who are beta- homozygotes and 40% who are carriers of at least one beta+ gene, is consistent with the Italian origin of most of these patients